This study day provides a comprehensive overview of acute kidney injury (AKI) and renal replacement therapy (RRT) in the critically ill patient.
This study day provides a comprehensive overview of the management of acute kidney injury (AKI) and renal replacement therapy (RRT) in the critically ill patient.
The day will address how AKI is identified and managed across the ICU through to the practical delivery of continuous renal replacement therapy (CRRT) and the complexities of the nephrology–ICU interface. Participants will develop their understanding of key clinical decisions in CRRT — including circuit anticoagulation, pharmacological and nutritional dosing adjustments, and the transition between modalities — supported throughout by expert-led case-based discussions and interactive debate.
The day will also explore AKI in the context of liver failure and electrolyte disturbances, particularly challenging patient cohorts, and will highlight the importance of multi-professional collaboration in optimising outcomes across the renal care pathway.
We will also review the revised KDIGO 2026 International AKI guidelines and highlight important new recommendations and changes.
09:00 - 09:10
Welcome and Introduction
Chairs: TBC
09:10 - 10:00
KDIGO Clinical Practice Guideline for AKI and AKD 2026 – Are we managing AKI in the ICU correctly?
Speaker: TBC
10:00 - 10:40
How to set up and monitor your citrate CRRT programme
Speaker: TBC
10:40 - 10:50
Q&A Session
Speakers and Chairs
10:50 - 11:00
Break
11:00 - 11:30
Nutritional requirements in CRRT
Speaker: TBC
11:30 - 12:00
Antibiotic dosing in AKI/CRRT
Speaker: TBC
12:00 - 12:10
Q&A Session
Speakers and Chairs
12:10 - 13:00
Lunch Break
13:00 - 13:45
Debate: Fluid (overload) management: Fast or Slow?
Speakers: TBC
13:45 - 14:25
Case-based discussion: Renal/ICU interface
Speakers: TBC
14:25 - 14:35
Q&A Session
Speakers and Chairs
14:35 - 14:45
Break
14:45 - 15:30
Case-based discussion: AKI and CRRT in liver failure
Speakers: TBC
15:30 - 16:15
Case-based discussion: Critical Care Nephrologist approach to acid base and electrolytes
Speaker:TBC
16:15 - 16:25
Q&A Session
Speakers and Chairs
16:25 - 16:30
Closing Remarks
Chairs: TBC
Pricing
All prices are VAT exempt. Members benefit from significantly reduced rates.
| Role | Member rate | Non-member rate |
|---|---|---|
| Consultant | £150 | £265 |
| SAS | £100 | £170 |
| Trainee | £100 | £170 |
| Nurse | £100 | £170 |
| AHP | £100 | £170 |
| Associate | £100 | £170 |
| ACCP | £100 | £170 |
| Pharmacist | £100 | £170 |
| Student | £50 | £75 |
Group bookings can be made for multiple delegates and paid by credit card via the event booking page.
We are also able to invoice for group bookings of 10 or more delegates, or where the total value is over £500. Group bookings can only be made up to 6 weeks in advance of an event and must be paid in full prior to the event date to avoid tickets being cancelled.
To book a group via invoice, please download the form below, complete and return to events@ics.ac.uk.
If you have any questions about the event or need any further assitance, please do contact us via:
Telephone: (+44) 0207 280 4350
Email:

Clinical Reader in Critical Care Nephrology, Queen Mary University of London and Consultant Intensivist & Nephrologist, Barts Health NHS Trust

Clinical Reader in Critical Care Nephrology, Queen Mary University of London and Consultant Intensivist & Nephrologist, Barts Health NHS Trust
Dr Prowle is Clinical reader in Critical Care Nephrology in the Critical Care and Perioperative Medicine Research Group at William Harvey Research Institute, Queen Mary University of London and is an Honorary Consultant Physician in Intensive Care Medicine and Renal Medicine at the Royal London Hospital, Barts Health NHS Trust.
Dr Prowle graduated with distinction in medicine from the University of Cambridge in 1999 and undertook Doctoral Research under the supervision of Prof Rinaldo Bellomo (the most published and highly cited researcher in the history of Australian Medicine) in Melbourne, Australia leading to the award of his MD research doctorate in 2012.
His research interests include the pathogenesis, diagnosis and outcomes of Acute Kidney Injury, Renal replacement Therapy in the ICU the Epidemiology of Critical Illness and its recovery and the impact of multi-morbidity of high risk surgical and ICU outcomes. Since 2009 he has co-authored over 160 peer-reviewed publications and 30 book chapters with an H-index of 51 (GS).
He is an active senior contributor to national and international collaborations in critical care nephrology including the Acute Disease Quality Initiative (ADQI), Kidney Disease Improving Global Outcomes AKI Group and the UK Kidney research Consortium Clinical Studies Group in AKI (as co-chair).
Please accept {{cookieConsents}} cookies to view this content